FEATURED COMPANIES
- Abbott Laboratories
- B. Braun Group
- Biotronik
- C.R. Bard (BD)
- Koninklijke Philips
- Minnetronix Inc.
The global atherectomy devices market exhibited moderate growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Atherectomy devices refer to various minimally invasive (MI) instruments used for peripheral vascular intervention procedures. They are designed to re-establish blood flow in the arteries by drilling, grinding, shaving, sanding and vaporizing plaque, calcifying lesions and excessive cellular material. Some of the commonly used atherectomy devices include direction, orbital, photo-ablative, rotational and support atherectomy devices. The devices consist of a rotating blade inside a tubular catheter attached to a battery-operated motor that spins the cutter and removes the plaque or calcified lesion. As a result, atherectomy devices find extensive applications in hospitals, surgical centers and ambulatory care centers.
The increasing prevalence of peripheral artery disease (PAD), atherosclerosis, diabetes and obesity, along with the rising geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, the growing preference for MI atherectomy surgical procedures among both patients and healthcare providers is creating a positive outlook for the market. These devices reduce the risks of infections, cause minimal pain and trauma during the surgery and facilitate faster recovery of the patient. Additionally, various product innovations, such as the development of drug-coated balloons (DCB), are acting as other growth-inducing factors. DCBs are used in place of permanent implants with directional atherectomy and anti-restenosis therapy (DAART) to deliver anti-proliferative drugs and treat lesions with severe calcifications. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.
The analyst provides an analysis of the key trends in each sub-segment of the global atherectomy devices market, along with forecasts at the global, regional and country level from 2021-2026. The report has categorized the market based on region, product, application and end user.
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Avinger, B. Braun Group, Biomerics, Biotronik, Boston Scientific, C.R. Bard (BD), Cardinal Health, Koninklijke Philips, Medtronic, Minnetronix Inc., Straub Medical AG (BD) and Terumo Corporation.
Atherectomy devices refer to various minimally invasive (MI) instruments used for peripheral vascular intervention procedures. They are designed to re-establish blood flow in the arteries by drilling, grinding, shaving, sanding and vaporizing plaque, calcifying lesions and excessive cellular material. Some of the commonly used atherectomy devices include direction, orbital, photo-ablative, rotational and support atherectomy devices. The devices consist of a rotating blade inside a tubular catheter attached to a battery-operated motor that spins the cutter and removes the plaque or calcified lesion. As a result, atherectomy devices find extensive applications in hospitals, surgical centers and ambulatory care centers.
The increasing prevalence of peripheral artery disease (PAD), atherosclerosis, diabetes and obesity, along with the rising geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, the growing preference for MI atherectomy surgical procedures among both patients and healthcare providers is creating a positive outlook for the market. These devices reduce the risks of infections, cause minimal pain and trauma during the surgery and facilitate faster recovery of the patient. Additionally, various product innovations, such as the development of drug-coated balloons (DCB), are acting as other growth-inducing factors. DCBs are used in place of permanent implants with directional atherectomy and anti-restenosis therapy (DAART) to deliver anti-proliferative drugs and treat lesions with severe calcifications. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation
The analyst provides an analysis of the key trends in each sub-segment of the global atherectomy devices market, along with forecasts at the global, regional and country level from 2021-2026. The report has categorized the market based on region, product, application and end user.
Breakup by Product
- Directional Atherectomy Devices
- Orbital Atherectomy Devices
- Photo-Ablative Atherectomy Devices
- Rotational Atherectomy Devices
- Support Devices
Breakup by Application
- Peripheral Vascular
- Cardiovascular
- Neurovascular
Breakup by End User
- Hospitals
- Ambulatory Surgery Centers
- Research Laboratories and Academic Institutes
Breakup by Region
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Avinger, B. Braun Group, Biomerics, Biotronik, Boston Scientific, C.R. Bard (BD), Cardinal Health, Koninklijke Philips, Medtronic, Minnetronix Inc., Straub Medical AG (BD) and Terumo Corporation.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- B. Braun Group
- Biotronik
- C.R. Bard (BD)
- Koninklijke Philips
- Minnetronix Inc.
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Atherectomy Devices Market
6 Market Breakup by Product
7 Market Breakup by Application
8 Market Breakup by End-user
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Note: Product cover images may vary from those shown
- Abbott Laboratories
- Avinger
- B. Braun Group
- Biomerics
- Biotronik
- Boston Scientific
- C.R. Bard (BD)
- Cardinal Health
- Koninklijke Philips
- Medtronic
- Minnetronix Inc.
- Straub Medical AG (BD)
- Terumo Corporation
Note: Product cover images may vary from those shown
LOADING...
